Provides financing to U.S. middle-market companies across all industries. Specializes in investments ranging from $10 million to $50 million per company. Now — the numbers.
This is an established company with proven profits.
The market pays 10.2× for every dollar of annual profit — cheap, which is either an opportunity or a warning.
No analyst target is on record for this company.
Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.
The stock trades 17% below its peak. The market has trimmed its expectations for the company.
The net profit margin is 80% — still a thick cushion, though costs have been eating into it lately.
It met or beat analyst expectations in 8 of the last 8 quarters — consistency is a promise kept.
It pays out $0.40 per share each year — regular cash for whoever holds the stock.
Over the last 2 years, sales fell about 33% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.
Since the drop from its peak, buyer appetite hasn’t come back.
We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the growth trend, the revenue breakdown.